Navigation Links
Optimer Reports First Quarter 2013 Financial Results
Date:5/9/2013

ract revenue

2,621,958-Other

-2,106Total revenues

19,435,49414,382,647Cost and expenses:Cost of product sales

1,634,4541,216,524Cost of contract revenue

1,656,0461,067,736Research and development

9,886,18511,067,967Selling, general and administrative

33,999,73325,522,282Co-promotion expenses with Cubist

3,750,00010,081,583Total operating expenses

50,926,41848,956,092Loss from operations

(31,490,924)(34,573,445)Gain of de-consolidation of OBI

-23,782,229Equity in net loss of OBI

-(485,969)Interest income and other, net

159,22576,387Consolidated net loss

$ (31,331,699)$  (11,200,798)Net loss attributable to non-controlling interest

-280,344Net loss attributable to Optimer Pharmaceuticals, Inc.

$ (31,331,699)$  (10,920,454)Net income (loss) per share - basic and diluted

$
(0.65)$
(0.23)Weighted average number of shares used to compute net  income (loss) per share - basic and diluted

47,884,21046,722,617Optimer Pharmaceuticals, Inc.Condensed Consolidated Balance SheetsMarch 31,December 31,20132012(unaudited)ASSETSCurrent assets:Cash and cash equivalents

$   87,964,542$ 119,444,586Short-term investments

5,385,1094,556,329Trade accounts receivable, net

7,062,7617,119,089Accounts receivable, other

3,939,2202,391,071Inventory

22,142,84615,061,771Prepaid expenses and other current assets

2,943,3883,442,717Total current assets

129,437,866152,015,563Property and equipment, net 

4,027,3554,338,720Long-term investments

-820,000Deferred tax assets, non-current

890,843890,843Other assets

1,070,3881,362,196Total assets

$ 135,426,452$ 159,427,322LIABILITIES  AND STOCKHOLDERS' EQUITY Current liabilities:Accounts payable

$
3,728,709$
7,166,127Accrued expenses


'/>"/>
SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
2. Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
3. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
4. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
5. Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference
6. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
7. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
8. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
9. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
10. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
11. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014 Sophia Genetics, ... domaine de l,analyse des données issues du SNG ... de diagnostic in vitro (IVD) du gène CFTR ... la mucoviscidose dans un seul essai SGN. La ... les types de variantes par l,intermédiaire d,un seul ...
(Date:9/30/2014)... 2014  Wrightington, Wigan and ... MDRX ) are delighted to announce WWL,s decision ... health information system. The system will be implemented across ... way WWL delivers healthcare in the future. ... of on-time and on-budget system implementations as well as ...
(Date:9/30/2014)... 2014 This study provides an analysis ... solutions including nuclear imaging informatics, PET imaging informatics, ... assesses the size of the market based on ... projects future growth based on the current drivers ... place in the broader markets for imaging equipment, ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 2Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 3Wrightington, Wigan and Leigh NHS Foundation Trust selects Allscripts Sunrise 4Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3
... 10, 2010 The American Council on Exercise (ACE), ... fitness certification, education and training organization in the world, ... will focus on eliminating obesity in America.  As an ... the critical need to regularly engage in physical activity ...
... 2010 Luminex Corporation (Nasdaq: LMNX ... the Stephens Fall Investment Conference to be held ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo:   ... Patrick J. Balthrop, president and chief executive officer, ...
Cached Medicine Technology:American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 2American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America 3Luminex Corporation to Present at Stephens Fall Investment Conference 2
(Date:10/1/2014)... Today marks the final day prosthodontist Dr. ... Oxnard and Woodland Hills, Calif., is in the southern ... , “Speaking to this group of specialists allows more ... the help and care they deserve,” Dr. Jivraj said. ... work, providing cosmetic dentistry, correcting bite issues, placing implants, ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Generic drug ... retail generics increasing in price in the last 12 ... Inc.’s (AIS) Drug Benefit News (DBN) interviewed a plan ... means for pharmacies and health plans. , “When ... rising generic acquisition costs, these cost increases squeeze pharmacies’ ...
(Date:10/1/2014)... October 01, 2014 UP4 Probiotics will ... WOMEN’S probiotic to The National Network to End Domestic ... This organization was chosen through nationwide polling that took ... social media outlets. , “We are proud to ... portion of every sale of UP4 Women’s Probiotics during ...
(Date:10/1/2014)... 2014 Long-acting insulin is safer and more ... 1 diabetes, according to new research published in ... at once-daily and twice-daily doses of both long- ... cost-effectiveness. , "In patients with Type 1 ... to intermediate-acting insulin when it came to controlling ...
(Date:10/1/2014)... 2014 This weekend Pope Francis drew world-wide ... Speaking to 40,000 seniors in St. Peter's Square in ... elderly. "Violence against the elderly is as inhuman as ... are old people just discarded, victims of an abandonment that ... a throw-away culture that is hurting our world so much," ...
Breaking Medicine News(10 mins):Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 2Health News:Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter 3Health News:UP4 Probiotics Partners with The National Network to End Domestic Violence 2Health News:Long-acting insulin is safer, more effective for patients with Type 1 diabetes 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 3
... software medication solution reduces complexity in, patient-specific medication ... ... LAS VEGAS, ASHP, Dec. 3 Ushering in ... OMCL ) a leading provider,of system solutions ...
... with Centers of Influence, POWAY, Calif., Dec. ... leading provider of medical diagnostic imaging systems,and services ... the signing of a letter of agreement with ... of the agreement, the fifth since the inception ...
... advertisements are appearing on television, the bulk of ... spend annually to market their products is targeted ... students. , A literature review by researchers ... the Regenstrief Institute, Inc. published in the December ...
... , , MONDAY, Dec. 3 (HealthDay News) -- Avandia, a ... bone loss, according to a new study conducted in mice. ... may speed osteoporosis, the thinning of the bones that can ... appear in the Dec. 2 online issue of Nature ...
... ANGELES, Dec. 2 Hurricane Katrina was one ... and was the costliest (at an,estimated $86 billion.) ... in the aftermath. Witnessing the,destruction/displacement from the West ... to take his new school training techniques, with,old ...
... Everything from Christmas trees to fake snow can trigger symptoms, ... It,s easy for the holidays to become the season ... or other allergies and asthma, say experts at the American ... preventive measures can cut symptoms to a minimum, they say. ...
Cached Medicine News:Health News:Omnicell Debuts Industry's First Total Automated Patient-Specific Management Solution 2Health News:Omnicell Debuts Industry's First Total Automated Patient-Specific Management Solution 3Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 2Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 3Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 4Health News:Do medical schools affect the way future doctors interact with drug companies? 2Health News:Diabetes Drug Avandia Could Weaken Bones 2Health News:CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors 2Health News:CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors 3Health News:'Tis the Season For Allergy, Asthma 2
... Millipore has developed a range of ... match specific water quality requirements. Each ... is designed to specifically target contaminants ... HPLC, molecular biology and ICP-MS. The ...
Adjustable speed vortex with inter-changeable heads , 110 V...
Inquire...
Adjustable speed vortex with inter-changeable heads, 110 V...
Medicine Products: